Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
Quest Diagnostics (NYSE: DGX) has been named to Fortune magazine's 2025 World's Most Admired Companies™ list for the 11th consecutive year. The company ranked third in the 'Health Care: Pharmacy and Other Services' category, achieving top positions in seven of nine evaluation criteria.
The selection process, conducted in collaboration with Korn Ferry, involved surveying thousands of executives, directors, and analysts who rated companies based on nine key attributes including quality of products and services, innovation, and social responsibility. Quest secured top 1 or 2 positions in areas such as quality of management, long-term investment, product and service quality, social responsibility, and people management.
With over 55,000 employees, Quest Diagnostics continues its mission of creating a healthier world under the leadership of Chairman, CEO and President Jim Davis. Companies must rank in the top half of their industry survey to be included in this prestigious list, which analyzed 650 companies in total.
Quest Diagnostics (NYSE: DGX) è stata inserita nella lista delle Società più Ammirate al Mondo™ di Fortune per il 11° anno consecutivo. L'azienda ha ottenuto il terzo posto nella categoria 'Salute: Farmacia e Altri Servizi', raggiungendo posizioni di vertice in sette dei nove criteri di valutazione.
Il processo di selezione, condotto in collaborazione con Korn Ferry, ha coinvolto un sondaggio tra migliaia di dirigenti, direttori e analisti che hanno valutato le aziende in base a nove attributi chiave, tra cui la qualità di prodotti e servizi, innovazione e responsabilità sociale. Quest ha ottenuto le prime posizioni (1 o 2) in aree come la qualità della gestione, l'investimento a lungo termine, la qualità di prodotti e servizi, la responsabilità sociale e la gestione delle persone.
Con oltre 55.000 dipendenti, Quest Diagnostics continua la sua missione di creare un mondo più sano sotto la guida del Presidente e CEO Jim Davis. Le aziende devono posizionarsi nella metà alta della loro indagine di settore per essere incluse in questa prestigiosa lista, che ha analizzato in totale 650 aziende.
Quest Diagnostics (NYSE: DGX) ha sido incluida en la lista de las Empresas Más Admiradas del Mundo™ de Fortune por undécimo año consecutivo. La compañía ocupó el tercer lugar en la categoría 'Salud: Farmacia y otros servicios', logrando posiciones destacadas en siete de los nueve criterios de evaluación.
El proceso de selección, llevado a cabo en colaboración con Korn Ferry, implicó encuestar a miles de ejecutivos, directores y analistas que calificaron a las compañías en función de nueve atributos clave, incluyendo la calidad de productos y servicios, innovación y responsabilidad social. Quest obtuvo posiciones entre las 1 o 2 en áreas como calidad de gestión, inversión a largo plazo, calidad de productos y servicios, responsabilidad social y gestión de personas.
Con más de 55,000 empleados, Quest Diagnostics continúa su misión de crear un mundo más saludable bajo el liderazgo del Presidente y CEO Jim Davis. Las empresas deben estar en la mitad superior de su encuesta sectorial para ser incluidas en esta prestigiosa lista, que analizó un total de 650 empresas.
퀘스트 진단(Quest Diagnostics, NYSE: DGX)는 포춘 매거진의 2025 세계에서 가장 존경받는 기업™ 목록에 11년 연속 이름을 올렸습니다. 이 회사는 '헬스케어: 약국 및 기타 서비스' 범주에서 3위를 차지하며, 9개의 평가 기준 중 7개에서 최고 위치를 기록했습니다.
선정 과정은 Korn Ferry와 협력하여 진행되었으며, 수천 명의 경영자, 이사 및 분석가가 참여하여 회사들을 제품 및 서비스의 품질, 혁신, 사회적 책임 등 9가지 주요 속성을 기준으로 평가했습니다. 퀘스트는 관리 품질, 장기 투자, 제품 및 서비스 품질, 사회적 책임 및 인력 관리와 같은 분야에서 1위 또는 2위의 성과를 기록했습니다.
55,000명 이상의 직원을 보유한 퀘스트 진단은 제임스 데이비스(Jim Davis) 회장 겸 CEO의 리더십 아래 건강한 세상을 만들기 위한 사명을 계속 이어가고 있습니다. 기업은 이 저명한 목록에 포함되기 위해 업계 조사에서 상위 절반에 들어야 하며, 총 650개의 회사가 분석되었습니다.
Quest Diagnostics (NYSE: DGX) a été inscrite dans la liste des Entreprises les plus admirées au monde™ de Fortune pour la 11ème année consécutive. L'entreprise a obtenu la troisième place dans la catégorie 'Santé : Pharmacie et autres services', atteignant les meilleures positions dans sept des neuf critères d'évaluation.
Le processus de sélection, réalisé en collaboration avec Korn Ferry, a impliqué une enquête auprès de milliers de dirigeants, directeurs et analystes qui ont évalué les entreprises en fonction de neuf attributs clés, notamment la qualité des produits et services, l'innovation et la responsabilité sociale. Quest a obtenu les premières ou secondes places dans des domaines tels que la qualité de la gestion, les investissements à long terme, la qualité des produits et services, la responsabilité sociale et la gestion des personnes.
Avec plus de 55 000 employés, Quest Diagnostics continue sa mission de créer un monde plus sain sous la direction de Jim Davis, Président et CEO. Les entreprises doivent se classer dans la moitié supérieure de leur enquête sectorielle pour être incluses dans cette prestigieuse liste, qui a analysé un total de 650 entreprises.
Quest Diagnostics (NYSE: DGX) wurde zum 11. Mal in Folge in die Liste der Weltweit am meisten bewunderten Unternehmen™ von Fortune aufgenommen. Das Unternehmen belegte in der Kategorie 'Gesundheitswesen: Pharmazie und andere Dienstleistungen' den dritten Platz und erzielte in sieben von neun Bewertungs-Kriterien Spitzenpositionen.
Der Auswahlprozess, der in Zusammenarbeit mit Korn Ferry durchgeführt wurde, umfasste eine Umfrage unter tausenden von Führungskräften, Direktoren und Analysten, die Unternehmen anhand von neun wichtigen Attributen bewerteten, darunter Produkt- und Servicequalität, Innovation und soziale Verantwortung. Quest sicherte sich die ersten 1 oder 2 Plätze in Bereichen wie Managementqualität, langfristige Investitionen, Produkt- und Servicequalität, soziale Verantwortung und Personalmanagement.
Mit über 55.000 Mitarbeitern setzt Quest Diagnostics seine Mission fort, eine gesündere Welt zu schaffen, unter der Leitung von Vorsitzendem, CEO und Präsidenten Jim Davis. Unternehmen müssen in der oberen Hälfte ihrer Branchenumfrage abschneiden, um in diese angesehene Liste aufgenommen zu werden, die insgesamt 650 Unternehmen analysiert hat.
- None.
- None.
The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, social responsibility, and talent management.
"Every day, the more than 55,000 colleagues of Quest Diagnostics bring our purpose to life: working together to create a healthier world, one life at a time," said Jim Davis, Chairman, CEO and President. "Their commitment to living our purpose in service to our customers and patients is the reason we continue to be recognized among Fortune's World's Most Admired Companies."
In addition to the overall ranking, Quest was number three in the "Health Care: Pharmacy and Other Services" industry category. Quest ranked in the top 1 or 2 spot of seven of nine criteria that comprise the industry category, including quality of management, long-term investment, product and service quality, social responsibility and people management.
Consulting firm Korn Ferry collaborated with Fortune to survey thousands of executives, directors and analysts who rated companies in their industry on nine criteria, analyzing a total of 650 companies. A company's score must rank in the top half of its industry survey to be listed as a World's Most Admired Company.
Find more information on the 2025 Fortune's World's Most Admired Companies here.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-named-to-fortunes-worlds-most-admired-companies-list-for-11th-consecutive-year-302364831.html
SOURCE Quest Diagnostics
FAQ
What ranking did Quest Diagnostics (DGX) achieve in Fortune's 2025 World's Most Admired Companies list?
How many evaluation criteria did DGX excel in for the 2025 Fortune ranking?
What was the selection process for Fortune's 2025 World's Most Admired Companies list?
How many employees does Quest Diagnostics have in 2025?